| SCHEDULED DISCIPLINE HEARINGS |
|---|
|
Wednesday, December 4, 2019 |
Planned Maintenance to eServices and Related Services - December 4
Required maintenance work to the College’s IT systems supporting eServices will take place on Wednesday, December 4 from 6:00PM to 11:00PM.
The highlights from the November Board Meeting are now available.
Topics include initial Continuing Education audits, pharmacy prescribing authority update, PODSA modernization phase II bylaw amendments and Professional Practice Policies, pharmacists' injecting authority update and more.
Both the College and the BC Pharmacy Association have received some concerns that the vial for the paralyzing agent rocuronium bromide (DIN 02318415) is visually very similar to the vial for the Fluviral influenza vaccine.
As recently approved by the Board, the College filed amendments to the Fee Schedules under the HPA Bylaws and PODSA Bylaws, with the Ministry of Health, in accordance with the College’s 2019/2020 budget. These fee increases were initially approved at the February 2019 meeting as part of the College’s...
We Want to Hear from You: How’s Our Service?
From October 25 - November 22, take the College’s Customer Satisfaction Survey and help us continue to improve our service standards!
Health Canada and Pfizer warn that some EpiPen and EpiPen Jr auto-injector devices may not slide out of their carrier tube easily, or at all.
The College would like to thank pharmacists in the Metropolitan Vancouver (District 1), Vancouver Island/Coastal (District 3), Northern BC (District 5), and Community Hospitals (District 7) that voted in the 2019 Board elections.
|
[Update - October 7, 2019] |
The highlights from the September Board Meeting are now available.
Highlights from this meeting include Medication Incident Reporting, the Rescheduling of Codeine Containing Liquid Preparations, Amendments to the Committee Members Terms of Office, Amendments to PPP-3: Pharmacy References, the College's next Strategic Plan and more.
Polls are now open for Metropolitan Vancouver (District 1), Vancouver Island/Coastal (District 3), Northern BC (District 5), and Community Hospitals (District 7).
The College is pleased to announce the following candidates for the upcoming College of Pharmacists of BC Board Election.
|
[Update - August 15, 2019] This temporary service outage has been extended until 9:00AM on Sunday August 18 |
The College of Pharmacists of BC’s Annual Report for the fiscal year 2018/2019 (March 1, 2018 to February 28, 2019) is now available at annualreport.bcpharmacists.org.
On July 3, 2019, the College of Pharmacists of BC is implementing important updates to its eServices web portal, including improving the security of registrant information.
The highlights from the June Board Meeting are now available.
Highlights from this Board Meeting include a number of PODSA modernization amendments, data from PRP’s Registrant Feedback Survey; and an update on the College’s organizational efforts with regards to Excellence Canada Certification and its next Strategic Plan.
The College’s Patient Relations Program Standard helps to protect public safety by providing clearer standards and requirements for dealing with misconduct of a sexual nature.
The highlights from the April Board Meeting are now available.
Highlights from this meeting include amendments to committee member terms of office, drug scheduling amendment of Esomeprazole, Controlled Prescription Program update, PODSA modernization phase 2 update, UBC Entry-to-Practice Doctor of Pharmacy Program, and more.
The highlights from the February Board Meeting are now available.
Highlights from this meeting include the Patient Relations Program Standard, amalgamation of committees, PODSA ownership update, guest presentations from the Therapeutics Initiative and BC Drug and Poison Information Centre, injection authority and more.
Call for Volunteer Committee Members 2019
The College is recruiting volunteers to serve on its committees!
A new Opioid Agonist Treatment Compliance and Management Program (OAT-CAMPP) for community pharmacy has been developed aimed at reducing stigma and expanding pharmacists’ knowledge about methadone, buprenorphine/naloxone and slow-release oral morphine.